Same Old, Same Old From The Fed

George Yacik - INO.com Contributor - Fed & Interest Rates


If we’re to believe the financial press, there is at least a 50-50 chance the Federal Reserve will raise interest rates at its next meeting on September 20-21. I’ll believe it when it actually happens – but not a minute before then.

The Wall Street Journal story on the release of the minutes of the Fed’s July 26-27 meeting last week, written by its senior Fed watcher Jon Hilsenrath, said the Fed announcement “suggested a rate increase is a possibility as early as September, but that the Fed won’t commit to moving until a stronger consensus can be reached about the outlook for growth, hiring and inflation.”

But haven’t we heard that before? All the Fed did was provide more of the same “let’s wait and see what happens before we do anything” prevarications.

“Members generally agreed that, before taking another step in removing monetary accommodation, it was prudent to accumulate more data in order to gauge the underlying momentum in the labor market and economic activity,” the Fed minutes actually said. “Members judged it appropriate to continue to leave their policy options open and maintain the flexibility to adjust the stance of policy based on incoming information.”

Sound familiar? Continue reading "Same Old, Same Old From The Fed"

Silver Miners Could Have Made You A Fortune

Aibek Burabayev - INO.com Contributor - Metals


At the start of this month, I shared with you the comparative dynamics of gold and gold stocks. I joked that the commodities traders could only envy the stock investors as the results of gold purchase were laughable compared to investing in stocks. And today I would love to show you an even more surprising results of silver stocks.

Part I. Comparison

Chart 1. Top Silver Stocks Vs. Silver: This Brilliant League Is Not For Metal
Top Silver Stocks Vs. Silver
Chart courtesy of tradingview.com
The above chart has a high resolution and to see it in a full size; please click on the chart. It shows us the comparative dynamics of silver and the top silver stocks by market cap.

The 5 stocks are sorted by market cap: Continue reading "Silver Miners Could Have Made You A Fortune"

The Presidential Nominees Are Set

Noah Kiedrowski - INO.com Contributor - Biotech


The political lines have been drawn, it’s Clinton verses Trump. I written several pieces evaluating the massive sell-offs in the biotech sector. Utilizing the iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) as a proxy, I proposed a loose correlation between opportunistic political posturing by political front-runners and the chronic price suppression of IBB. I content that political posturing played a significant role in the sell-off of the healthcare cohort and more specifically biotech stocks. Drug pricing was used as a centerpiece as the scapegoat for political gains. Throughout this political process, this rhetoric has negatively impacted the sector. IBB fell from $401 in July of 2015 to $240 in February of 2016 or alternatively a 40% hit. This sell-off coincided with political rhetoric aimed at the collective cohort of healthcare and biotech companies. I strongly felt that these events were seasonal and would eventually subside without any significant impact to the underlying stocks within IBB. I felt this political induced sell-off presented a great buying opportunity after the 40% decline. I put my money where my mouth was by purchasing two tranches of IBB at a strike price of $250 in February and June during the market-wide sell-off and the Brexit, respectively. I feel that this is great entry point for any long-term investor that desires exposure to the biotechnology sector.

Are Drug Prices Really The Culprit?

In terms of the overall cost to the healthcare system, drugs comprise less than 10% of the pie. Allergan CEO Brent Saunders stated in an interview with Jim Cramer on Mad Money (Figure 1): Continue reading "The Presidential Nominees Are Set"

BoE Easing Will Be Short-Lived

Lior Alkalay - INO.com Contributor - Forex


The UK economy is sending mixed signals of resilient performance and negative sentiment. The latest PMI readings, both in services and manufacturing, plunged below 50, signaling a contraction. Consumer confidence took a nosedive to -12 in July from a -1 reading just a month before. And in the real estate sector, the latest survey of the Royal Institution of Chartered Surveyors of estate agents showed that only 23% of the participants expected housing prices to rise in the next twelve months.

The Bank of England, at its August meeting, responded with sweeping measures to ease monetary conditions. The BoE cut the benchmark interest rate by 25 bps to 0.25%, eased capital requirements for UK banks which will free up £150 billion of liquidity, and the “crown jewel” – a new round of £60 billion in Quantitative Easing, bringing the QE total to £435 billion.

Nevertheless, Key data released in the UK this week suggests that the overall economy is rather resilient, with unemployment holding at 4.9% and core inflation falling only moderately, from 1.4% to 1.3% year-on-year.

So where is UK economy heading? Continue reading "BoE Easing Will Be Short-Lived"

OPEC Oil Export Revenues Lowest Since 2003

Robert Boslego - INO.com Contributor - Energies


But No Agreement To Cut Production Likely

OPEC President, H.E. Dr. Mohammed Bin Saleh Al-Sada, Qatar's Minister of Energy and Industry, issued a press release August 8th announcing that an informal meeting of OPEC member countries would take place on the sidelines of the 15th International Energy Forum in Algeria from 26 to 28 September 2016. There was an initial price rise, but that faded on Tuesday and Wednesday. Continue reading "OPEC Oil Export Revenues Lowest Since 2003"